26Jun
Financial Daily Dose 6.25.2019 | Top Story: Allergan and AbbVie Combine Forces in $63 Billion Deal
Massive pharma news to start the day, with AbbVie announcing that it’s reached a deal to buy Allergan for roughly $63 billion. The tie-up is seen as giving AbbVie a “dominant position in the $8 billion-plus market for Botox and other beauty drugs” is...
By:
Robins Kaplan LLP
Related
The Southern District of New York declared that plaintiff Monjasa A/S was not bound by an arbitratio...
Read More >
The year-end federal spending bill, the Further Consolidated Appropriations Act, 2020 (“FCAA”), wa...
Read More >
In September 2020, the FTC announced that it would be proposing a series of changes to the Hart-Scot...
Read More >
In this episode of Trekking Through Compliance, we consider the episode And the Children Shall Lead ...
Read More >
The US Department of the Treasury has issued two final regulations implementing the Foreign Investme...
Read More >
The Miller Act protects subcontractors from nonpayment on federal projects by requiring prime contra...
Read More >